BARRIERS TO INITIATE INSULIN THERAPY AND ITS ASSOCIATION WITH DURATION OF DIABETES MELITIS AND DEMOGRAPHIC FACTORS IN UNCONTROLLED TYPE 2 DIABETIC PATIENTS, A CROSS SECTIONAL STUDY
DOI:
https://doi.org/10.33279/jkcd.v14i03.624Abstract
Objectives: To determine different barriers to initiate insulin therapy and association of duration of diabetes mellitus and demographic factors with barriers in initiation of insulin therapy in Uncontrolled type 2 diabetic patients.
Materials and Methods: We conducted a cross sectional study conducted among patients with type 2 diabetic patients presenting to endocrinology outpatient clinics in two Tertiary care hospitals of Peshawar ie. Khyber Teaching hospital and hayatabad medical complex Peshawar. The duration of study was 03 months after approval of synopsis. The sample size was 257.The study population was selected by consecutive non probability sampling technique. The data was collected by pre designed questionnaire. All the included patients were interviewed on pre designed questionnaire. Data was processed in SPSS version 22.
Results: In study we found that patients face different barriers to initiate insulin therapy. In our study, side effects of insulin was the barrier for 97(37.7%) of the patient, difficulty in carrying insulin was barrier for 128(49.8%) patients , dose adjustment of insulin was barrier for 90(35%) patients, fear if insulin needle was barrier for 89 (34.6%) patients, self administration of insulin was barrier for 98(38.1%) patients , affordability of insulin was barrier accounting for 114(44%) patients , frightened about insulin therapy by someone was barrier for116 (45.1%) patients. The association between economic status of patient and the barrier that they are frightened by someone was statistically significant. Chi-square test was also run between duration of diabetes with all barriers in which one association was found nearly signifi cant i.e. the association of duration of diabetes with difficulty in carrying insulin with the p value of 0.064.
Conclusion: The most common barrier in insulin therapy initiation of patients in the study was difficulty in carrying insulin. We found that there is near to signifi cant association between duration of diabetes and difficulty in carrying insulin. There is significant association between economic status of patient and frightened by someone. The lower the economic status the more frightened about Insulin use.
References
Akram T Kharroubi and Hisham M Darwish,Diabetes mellitus: The epidemic of the century,information World
J Diabetes. 2015 Jun 25; 6(6): 850–867.Published online 2015 Jun 25.
Mirahmadizadeh A, Delam H, Seif M, Banihashemi SA, Tabatabaee H. Factors aff ecting insulin compliance in patients with type 2 diabetes in South Iran, 2017: we are faced with insulin Phobia. Iran J Med Sci. 2019;44(3):204–13.
Nguyen A, Mui K. The Staggering True Cost of Diabetes. 2020. p. 30.
Alhagawy, A.J, Yafei S, Hummadi A, Abutaleb R, Hakamy M, Alzughbi T. Barriers and Attitudes of Primary Healthcare Physicians to Insulin Initiation and Intensification in Saudi Arabia. Int. J. Environ. Res. Public Health 2022, (19) 167-94.
Abu Hassan H, Tohid H, Mohd Amin R, Long Bidin MB, Muthupalaniappen L, Omar K. Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration. BMC Fam Pract. 2013 (14)164-67
Hussein A, Mostafa A, Areej A, Mona AM, Shimaa A, Najd AG, Futoon A. The perceived barriers to insulin therapy among type 2 diabetic patients. Afr Health Sci. 2019 Mar;19(1):1638-46.
Taylor S, Thompson F, McDermott R. Barriers to insulin treatment among Australian Torres Strait Islanders with
poorly controlled diabetes. Aust J Rural Health. 2016 Dec;24(6):363-70
Russell-Jones D, Pouwer F, Khunti K. Identification of barriers to insulin therapy and approaches to overcoming them. Diabetes Obes Metab. 2018;20:488–496.
Arshad I, Mohsin S, Iftikhar S, Kazmi T, Nagi LF. Barriers to the early initiation of Insulin therapy among diabetic patients coming to diabetic clinics of tertiary care hospitals. Pak J Med Sci. 2019 Jan 35(1):39-44
Amin Hussein, Arafa Mostafa, Alnomi Areej,1 Al-muteb Mona, Alduaiji Shimaa,Al-Gazlan Najd, and Alnemari Futoon,The perceived barriers to insulin therapy among type 2 diabetic patients,African Health Sciences,Afr Health Sci. 2019 Mar; 19(1): 1638–1646
Masooma Hashmi. (2021). Myths & Barriers to Insulin Therapy in the patients of Diabetes Melitus. MedERA - Journal of CMH LMC and IOD, 2.
Ruaa Naji Zidane*, Wijdan Akram Hussein,Barriers for Insulin Therapy Initiation among Type 2 Diabetic Patients Attending the Specialized Center for Endocrinology and Diabetes / Baghdad, The Iraqi Postgraduate Medical Journal, 2019 ,VOL. 20, No. 2, 2021
Elkarim SA, Abdelaziz SI. Barriers to Insulin Therapy in Adult Patients with Type Two Diabetes Mellitus at Family Medicine Health Centers. Int J Fam Med Prim Care. 2021; 2(6): 1054.
Liu, C., De Roza, J., Ooi, C.W. et al. Impact of patients’ beliefs about insulin on acceptance and adheraence to insulin therapy: a qualitative study in primary care. BMC Prim. Care 23, 15 (2022).
MR Shafi e Pour,T Sadeghiyeh,M Hadavi,M Besharati & R Bidaki,The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran,Diabetes Metab Syndr Obes. 2019; 12: 1349–1354.
Ghadiri-Anari A, Fazaelipoor Z, Mohammadi SM. Insulin refusal in Iranian patients with poorly controlled type 2 diabetes mellitus. Acta Med Iran. 2013 Sep 9;51(8):567-71
Ng CJ, Lai PS, Lee YK, Azmi SA, Teo CH. Barriers and facilitators to starting insulin in patients with type 2 diabetes: a systematic review. Int J Clin Pract. 2015 Oct;69(10):1050-70.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Dr Imran ullah Dr Imran ullah
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
Share-copy and redistribute the material in any medium or format.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Attribution-You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial-You may not use the material for commercial purposes.
NoDerivatives-If you remix, transform, or build upon the material, you may not distribute the modified material.
No additional restrictions-You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
